Hematologic Diseases

Showing 26 - 50 of 143

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematological Abnormalities in Children

Not yet recruiting
  • Hematologic Diseases
  • sampling
  • (no location specified)
Sep 14, 2022

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +9 more
Sep 9, 2022

Gulf Long-Term Follow-Up Study

Active, not recruiting
  • Cardiovascular Disease
  • +4 more
    • Durham, North Carolina
      Social & Scientific Systems
    Aug 24, 2022

    Hematopoietic Stem Cell Transplantation, Hematologic Diseases, Sexual Dysfunction Trial in Boston (Enhanced Standard Care,

    Recruiting
    • Hematopoietic Stem Cell Transplantation
    • +2 more
    • Enhanced Standard Care
    • Multimodal Intervention to Address Sexual Dysfunction
    • Boston, Massachusetts
      Massachusetts General Hospital
    Aug 23, 2022

    Testosterone, Transsexualism, Hematologic Diseases Trial (Testosterone Cypionate 100 MG/ML)

    Not yet recruiting
    • Testosterone
    • +2 more
    • Testosterone Cypionate 100 MG/ML
    • (no location specified)
    Aug 1, 2022

    Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)

    Not yet recruiting
    • Beta-Thalassemia
    • +6 more
    • CTX001
    • (no location specified)
    Jul 26, 2022

    Infections, Heart Failure, COPD Exacerbation Trial in Boston (Health Information Exchange (HIE) platform)

    Not yet recruiting
    • Infections
    • +15 more
    • Health Information Exchange (HIE) platform
    • Boston, Massachusetts
      Brigham & Women's Hospital
    Jun 29, 2022

    Cancer, Sickle Cell Thalassemia, Hematologic Diseases Trial in Brussels (Autologous testicular tissue transplantation of

    Recruiting
    • Cancer
    • +2 more
    • Autologous testicular tissue transplantation of prepubertal frozen testicular tissue
    • Brussels, Belgium
      UZ Brussel Centre for Reproductive Medicine
    Jun 7, 2022

    Multiple Myeloma, Tumor, Plasma Cell, Tumors by Histologic Type Trial in United States (CYNK-001)

    Active, not recruiting
    • Multiple Myeloma
    • +19 more
    • CYNK-001
    • Denver, Colorado
    • +8 more
    May 24, 2022

    Vital Signs and Automated Alerts in Hospitalized Patients

    Not yet recruiting
    • Surgical Complication
    • +5 more
    • Vital signs measurements with new app
    • (no location specified)
    May 17, 2022

    Hematologic Diseases, Chemo Effect Trial in France (MaaT033 capsule)

    Completed
    • Hematologic Diseases
    • Chemotherapy Effect
    • MaaT033 capsule
    • Angers, France
    • +3 more
    Apr 11, 2022

    Hematologic Diseases, Stem Cell Transplantation Trial in Besançon, Nancy (Blood sample)

    Recruiting
    • Hematologic Diseases
    • Stem Cell Transplantation
    • Blood sample
    • Besançon, France
    • +1 more
    Apr 5, 2022

    Using Genomics in Inherited Bone Marrow Failure (IBMDx Study)

    Recruiting
    • Inherited BMF Syndrome
    • +2 more
    • whole genome and transcriptome sequencing
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    Mar 28, 2022

    Hematologic Diseases Trial in Palo Alto (biological, device, drug)

    Recruiting
    • Hematologic Diseases
    • Allogeneic Stem Cell Transplant
    • +2 more
    • Palo Alto, California
      Lucile Packard Children's Hospital
    Mar 25, 2022

    Multiple Myeloma, Renal Impairment, Tumors, Plasma Cell Trial in Greece (Isatuximab, Bortezomib, Cyclophosphamide)

    Not yet recruiting
    • Multiple Myeloma
    • +7 more
    • Athens, Greece
    • +5 more
    Mar 28, 2022

    Multiple Myeloma, Renal Impairment, Tumors, Plasma Cell Trial in Greece (Isatuximab, Pomalidomide, Dexamethasone)

    Not yet recruiting
    • Multiple Myeloma
    • +7 more
    • Athens, Greece
    • +5 more
    Mar 17, 2022

    Hematopoietic Stem Cell Transplant, Hematologic Diseases, Physical Activity Trial in Hershey (Exercise, Prehabilitation

    Recruiting
    • Hematopoietic Stem Cell Transplant
    • +3 more
    • Exercise
    • Prehabilitation Education
    • Hershey, Pennsylvania
      Penn State Cancer Institute
    Mar 18, 2022

    Automatic Method of Counting and Classify Bone Marrow and

    Recruiting
    • Hematologic Diseases
    • +2 more
    • there are not any interventions in this study
    • Taipei, Taiwan
      National Taiwan University Tai-Chen Cell Therapy Center
    Mar 9, 2022

    Hematologic Diseases, Diagnoses Disease, Pain Trial in Caen (sophrology)

    Completed
    • Hematologic Diseases
    • +2 more
    • sophrology
    • Caen, France
      Caen University Hospital
    Mar 2, 2022

    Brain Tumor, Neurofibromatoses, Sarcoma Trial in Worldwide ("My Logbook! - I know my way around!")

    Recruiting
    • Brain Tumor
    • +5 more
    • "My Logbook! - I know my way around!"
    • Linz, Oberösterreich, Austria
    • +26 more
    Feb 7, 2022

    Data of Current FVIII Prophylaxis Replacement Therapy in Adult

    Active, not recruiting
    • Blood Coagulation Disorder
    • +8 more
    • Standard of Care FVIII Replacement therapy
    • San Francisco, California
    • +10 more
    Feb 18, 2022

    Eosinophilia, Hypereosinophilic Syndrome, Leukocyte Disorder Trial run by the NIAID (prednisone)

    Completed
    • Eosinophilia
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 26, 2022

    Thrombotic Microangiopathies, Hematologic Diseases Trial in Suzhou (N-Acetylcysteine, Placebo Oral Tablet)

    Completed
    • Thrombotic Microangiopathies
    • Hematologic Diseases
    • Suzhou, Jiangsu, China
      The First affiliated Hospital of SooChow University
    Jan 19, 2022

    Adeno-Associated Virus (AAV), Blood Coagulation Disorder, Blood Coagulation Disorders, Inherited Trial in United States

    Recruiting
    • Adeno-Associated Virus (AAV)
    • +16 more
    • SPK-8016
    • Los Angeles, California
    • +13 more
    Feb 3, 2022

    Respiratory System Agents, Anti-Asthmatic Agents, Hematologic Diseases Trial run by the NIAID (benralizumab, Placebo)

    Active, not recruiting
    • Respiratory System Agents
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 20, 2022